Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan

Sales of Kiniksa Pharmaceuticals' biggest product, Arcalyst, are expected to begin declining in 2030. But the company has a plan. The post Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan appeared first on Investor's Business Daily.